Dabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alternative to warfarin in patients with atrial fibrillation. We evaluated the use of dabigatran in patients with mechanical heart valves.status: publishe
Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach epidemic pro...
Background: Atrial fibrillation (AF) is an arrhythmia that increases the risks of blood clots, strok...
Warfarin is recognized as the standard antithrombotic agent for stroke prevention. However, new oral...
BackgroundDabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alt...
It is with great interest we have read the paper by Eikelboom et al. recently published in The New E...
Objective: Warfarin reduces risk of stroke in patients with mechanical heart valves but increases ri...
INTRODUCTION: Oral anticoagulation is the mainstay for stroke and thromboembolic event prevention in...
Background Vitamin K antagonists are the only oral anticoagulants approved for long-term treatment o...
Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial...
BACKGROUND: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases t...
BACKGROUND: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases ...
ObjectiveWarfarin reduces risk of stroke in patients with mechanical heart valves but increases risk...
Oral anticoagulation is the cornerstone of stroke prevention in non-valvular atrial fibrillation (AF...
For the last 60 years warfarin has been the cornerstone for chronic anticoagulation in prevention of...
To the Editor: Although Connolly et al. (Sept. 17 issue)1 have demonstrated a modest advantage for d...
Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach epidemic pro...
Background: Atrial fibrillation (AF) is an arrhythmia that increases the risks of blood clots, strok...
Warfarin is recognized as the standard antithrombotic agent for stroke prevention. However, new oral...
BackgroundDabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alt...
It is with great interest we have read the paper by Eikelboom et al. recently published in The New E...
Objective: Warfarin reduces risk of stroke in patients with mechanical heart valves but increases ri...
INTRODUCTION: Oral anticoagulation is the mainstay for stroke and thromboembolic event prevention in...
Background Vitamin K antagonists are the only oral anticoagulants approved for long-term treatment o...
Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial...
BACKGROUND: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases t...
BACKGROUND: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases ...
ObjectiveWarfarin reduces risk of stroke in patients with mechanical heart valves but increases risk...
Oral anticoagulation is the cornerstone of stroke prevention in non-valvular atrial fibrillation (AF...
For the last 60 years warfarin has been the cornerstone for chronic anticoagulation in prevention of...
To the Editor: Although Connolly et al. (Sept. 17 issue)1 have demonstrated a modest advantage for d...
Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach epidemic pro...
Background: Atrial fibrillation (AF) is an arrhythmia that increases the risks of blood clots, strok...
Warfarin is recognized as the standard antithrombotic agent for stroke prevention. However, new oral...